Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis. - Wikidata - wikimedia - TriplyDB

Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis.

Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis.

http://www.wikidata.org/entity/Q37205173

about

Tumor necrosis factor blockade and the risk of viral infection Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: A literature review.Side effects of TNF-α blockers in patients with psoriatic arthritis: evidences from literature studies.

P2860

Q35161630-246B9D25-8571-4D80-B1B8-99DE41672A0B Q35705082-21A0765C-EEB6-4380-BBC5-567BBA48217A Q38099248-37E1EEF5-2CFF-4A39-A20B-44A931DF3BC4

P2860

Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis.

http://www.wikidata.org/entity/Q37205173

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on March 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis.

@en

Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis.

@nl

type

label

Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis.

@en

Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis.

@nl

prefLabel

Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis.

@en

Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis.

@nl

P1433

Q37205173-59308E6A-57F7-49C2-B255-6A9A6DF3EA20

P1476

Q37205173-A7407573-EE77-4295-8B6A-454543B9545D

P2093

Q37205173-20F609DD-5182-42F5-A68F-535DDDD4166A

Q37205173-36EB13AA-6ED3-41AE-A28D-B7A36B59D9E2

Q37205173-81A32B10-9400-4FA8-906E-40275BA0660E

Q37205173-E46A4417-97FC-43B5-BC80-53EC135FE7C8

Q37205173-F04FE7FD-CDB5-47D3-BD92-F01F7A5D76C1

Q37205173-FF2D19F5-1B28-4EA3-ACE1-A92742485453

P2860

Q37205173-35D2BE34-C313-4CFE-A50F-FB2F4ACB42BD

Q37205173-6D358AC9-88C3-4910-BC76-9B4B75D7749B

Q37205173-6DEBE8AB-CC45-4A07-8FEC-71B0E0224CBC

Q37205173-71DD32A9-80C6-4FF1-9495-07E71AC7C84D

Q37205173-7F64E237-7707-406B-9488-5137777171F8

Q37205173-883E68AA-E01D-4B8D-A995-B2D995EBE8CC

Q37205173-9912F037-7379-4789-82B1-0333DB951368

Q37205173-B4559675-4290-4DCC-92D3-26EE8EFC61D5

Q37205173-DE471DCB-1AF8-4448-A61F-0E6630E95083

P304

Q37205173-EF8000B4-4B32-4A7E-826E-FEF80CE1B12C

P31

Q37205173-6AE9076B-F126-42F5-8385-89B02A47D6DA

Q37205173-dc52f7a9-fddc-4e8e-955a-9f82aa909794

P356

Q37205173-78BB8EBA-1691-46F3-A511-1AFBAA09C9D6

P433

Q37205173-D95E9591-BCD1-4E19-8F8A-AC32C34290C1

P478

Q37205173-A904BBE7-813F-4A8E-A0B0-01D97E215763

P577

Q37205173-41B624B8-50D1-424C-A7CD-F1501CCFABC0

P5875

Q37205173-3BA6D2EB-A903-4E84-9DB1-C62DF2990D8F

P698

Q37205173-CD1BC78B-4CE4-44DA-A307-E5488C00984D

P921

Q37205173-9AECA7E7-B5A3-42B5-BBF6-2C78056BDDCE

Q37205173-BAF93061-11B1-4E04-B8FA-DC486ADAA63D

P932

Q37205173-4B678595-9554-4E9E-9ED4-1F4874DF2391

P356

KJIM.2007.22.1.63

P1433

The Korean journal of internal medicine

P1476

Adenoviral pneumonia during etanercept treatment in a patient with rheumatoid arthritis.

@en

P2093

Eun-Hwa Choi

http://www.w3.org/2001/XMLSchema#string

Hee-Jung Choi

http://www.w3.org/2001/XMLSchema#string

Kyoung-Eun Lee

http://www.w3.org/2001/XMLSchema#string

Min-Jung Kang

http://www.w3.org/2001/XMLSchema#string

Myung-Sin Kim

http://www.w3.org/2001/XMLSchema#string

You-Kyoung Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Immunomodulatory functions encoded by the E3 transcription unit of adenoviruses.

Experience with etanercept in an academic medical center: are infection rates increased?

Infections and biological therapy in rheumatoid arthritis.

Fatal disseminated adenovirus infections in immunocompromised patients.

Infections and anti-tumor necrosis factor alpha therapy.

Drugs that block tumour necrosis factor: experience in patients with rheumatoid arthritis.

Lung injury linked to etanercept therapy.

Infections in patients with rheumatoid arthritis treated with biologic agents.

Granulomatous infectious diseases associated with tumor necrosis factor antagonists.

P304

63-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3904/KJIM.2007.22.1.63

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2007-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6400103

http://www.w3.org/2001/XMLSchema#string

P698

17427651

http://www.w3.org/2001/XMLSchema#string

P921

P932

2687603

http://www.w3.org/2001/XMLSchema#string